These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Assay of plant tyrosinase by agar-gel double diffusion and electro-osmophoresis. John VT; Ragetli HW Biochem J; 1966 Nov; 101(2):21C-22C. PubMed ID: 4961062 [No Abstract] [Full Text] [Related]
4. Tyrosine hydroxylation catalyzed by mammalian tyrosinase: an improved method of assay. Pomerantz SH Biochem Biophys Res Commun; 1964 Jun; 16(2):188-94. PubMed ID: 5871805 [No Abstract] [Full Text] [Related]
5. Separation and characterization of multiple forms of tyrosinase from mouse melanoma. Burnett JB; Seiler H; Brown IV Cancer Res; 1967 May; 27(5):880-9. PubMed ID: 4960889 [No Abstract] [Full Text] [Related]
6. QUANTITATIVE DETERMINATION OF DOPA; ITS APPLICATION TO MEASUREMENT OF DOPA IN URINE AND IN THE ASSAY OF TYROSINASE IN SERUM. TAKAHASHI H; FITZPATRICK TB J Invest Dermatol; 1964 Jan; 42():161-5. PubMed ID: 14110908 [No Abstract] [Full Text] [Related]
7. Identification of 3,4-dihydroxyphenylalanine as tyrosinase cofactor in melanoma. Pomerantz SH; Warner MC Biochem Biophys Res Commun; 1966 Jul; 24(1):25-31. PubMed ID: 4961079 [No Abstract] [Full Text] [Related]
9. The tyrosine hydroxylase activity of mammalian tyrosinase. Pomerantz SH J Biol Chem; 1966 Jan; 241(1):161-8. PubMed ID: 5294951 [No Abstract] [Full Text] [Related]
10. [Continuous determination of phenylalanine and tyrosine decarboxylase activity]. Berjonneau AM; Canh-Tran-Minh ; Broun G C R Acad Hebd Seances Acad Sci D; 1972 Jul; 275(1):121-4. PubMed ID: 4631531 [No Abstract] [Full Text] [Related]
11. AN ENZYMATIC AND ELECTRON MICROSCOPIC CHARACTERIZATION OF A VARIANT OF THE CLOUDMAN S-91 MELANOMA. HIRSCH HM; ZELICKSON AS Cancer Res; 1964 Aug; 24():1137-53. PubMed ID: 14216148 [No Abstract] [Full Text] [Related]
12. In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells. Morrison ME; Yagi MJ; Cohen G Proc Natl Acad Sci U S A; 1985 May; 82(9):2960-4. PubMed ID: 3921968 [TBL] [Abstract][Full Text] [Related]
13. Tyrosinase inhibitor in Fortner's amelanotic and melanotic malignant melanoma. Satoh GJ; Mishima Y J Invest Dermatol; 1967 Apr; 48(4):301-3. PubMed ID: 6067129 [No Abstract] [Full Text] [Related]
15. Tyrosinase activity in serum from normal and melanoma-bearing mice. Menon IA; Haberman HF Cancer Res; 1968 Jul; 28(7):1237-41. PubMed ID: 4969868 [No Abstract] [Full Text] [Related]
16. On the purification and properties of mushroom tyrosinase. Nakamura T; Sho S; Ogura Y J Biochem; 1966 May; 59(5):481-6. PubMed ID: 4289813 [No Abstract] [Full Text] [Related]
17. Tyrosinase exhibits lag at pH 6.8 under steady state concentrations of tyrosine and 3,4-dihydroxy phenyl alanine in melanoma tissue. Chintamaneni C; Nadimpalli AR; Abburi R Indian J Biochem Biophys; 1991; 28(5-6):408-11. PubMed ID: 1812074 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of growth and respiration of melanomas by tyrosinase inhibitors. Demopoulos HB; Gerving MA; Bagdoyan H J Natl Cancer Inst; 1965 Nov; 35(5):823-7. PubMed ID: 5849594 [No Abstract] [Full Text] [Related]
19. Cholinesterase and tyrosinase activity in malignant melanoma. Mishima Y Cancer; 1966 May; 19(5):665-73. PubMed ID: 4160261 [No Abstract] [Full Text] [Related]
20. [Utilization of melanin precursors for experimental chemotherapy of malignant melanoma]. Jimbow K; Miura S; Ito Y; Kasuga T; Ito S Gan To Kagaku Ryoho; 1984 Oct; 11(10):2125-32. PubMed ID: 6435538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]